89.28

2.89% -2.655

Lantheus Holdings Inc (LNTH)

Overview News Price History Option Chain Financials Why LNTH Down? Discussions Forecast

Lantheus Holdings Inc stock is traded at $89.28, with a volume of 1.92M. It is down -2.89% in the last 24 hours and up +3.28% over the past month. Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Previous Close:

$91.94

Open:

$91.05

24h Volume:

1.92M

Relative Volume:

1.92

Market Cap:

$6.21B

Revenue:

$1.50B

Net Income/Loss:

$427.61M

P/E Ratio:

62.44

EPS:

1.43

Net Cash Flow:

$423.98M

1W Performance:

-4.02%

1M Performance:

+3.28%

6M Performance:

+9.58%

1Y Performance:

+53.38%

1-Day Range:

$88.56

$91.69

1-Week Range:

$88.56

$96.46

52-Week Range:

$50.20

$126.89

Lantheus Holdings Inc Stock (LNTH) Company Profile

Name

Lantheus Holdings Inc

Sector

Healthcare (1176)

Industry

Drug Manufacturers - Specialty & Generic (84)

Phone

978 671-8001

Address

331 TREBLE COVE ROAD, NORTH BILLERICA, MA

Employee

834

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

LNTH's Discussions on Twitter

Compare LNTH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LNTH Lantheus Holdings Inc	89.28	6.21B	1.50B	427.61M	423.98M	6.01
ZTS Zoetis Inc	164.84	74.37B	9.15B	2.43B	2.31B	5.32
HLN Haleon Plc Adr	9.69	43.81B	14.26B	1.55B	0	0.3383
TAK Takeda Pharmaceutical Co Adr	13.10	41.53B	30.27B	1.93B	3.45B	0.6044
TEVA Teva Pharmaceutical Industries Ltd Adr	22.09	25.03B	16.77B	-959.00M	1.37B	-0.85
VTRS Viatris Inc	12.52	14.94B	15.05B	-883.30M	1.89B	-0.74

Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-18-24	Initiated	Goldman	Buy
Sep-03-24	Initiated	Redburn Atlantic	Buy
Jul-10-24	Reiterated	JMP Securities	Mkt Outperform
Dec-18-23	Downgrade	William Blair	Outperform → Mkt Perform
Dec-04-23	Initiated	TD Cowen	Outperform
Sep-29-23	Initiated	William Blair	Outperform
Mar-08-23	Initiated	JMP Securities	Mkt Outperform
Nov-30-22	Initiated	SVB Leerink	Outperform
Oct-13-22	Initiated	Mizuho	Buy
May-09-22	Initiated	B. Riley Securities	Buy
Apr-13-22	Initiated	Truist	Buy
Feb-01-21	Initiated	SVB Leerink	Outperform
Jun-29-20	Resumed	Jefferies	Buy
Aug-16-19	Upgrade	CJS Securities	Market Perform → Market Outperform
Nov-02-17	Upgrade	Wells Fargo	Market Perform → Outperform
Nov-08-16	Reiterated	RBC Capital Mkts	Outperform
Sep-23-16	Resumed	Credit Suisse	Neutral
Feb-24-16	Reiterated	RBC Capital Mkts	Outperform
Dec-11-15	Downgrade	Credit Suisse	Outperform → Neutral
Sep-30-15	Downgrade	Wells Fargo	Outperform → Market Perform
Jul-20-15	Initiated	Credit Suisse	Outperform
Jul-20-15	Initiated	Jefferies	Buy
Jul-20-15	Initiated	RBC Capital Mkts	Outperform
Jul-20-15	Initiated	Robert W. Baird	Outperform
Jul-20-15	Initiated	Wells Fargo	Outperform

View All

Lantheus Holdings Inc Stock (LNTH) Latest News

Dec 20, 2024

Lantheus (NASDAQ:LNTH) Trading Down 2.2%Here's Why - MarketBeat

Dec 20, 2024

Lantheus Holdings, Inc. (NASDAQ:LNTH) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Dec 20, 2024

World Investment Advisors LLC Takes Position in Lantheus Holdings, Inc. (NASDAQ:LNTH) - MarketBeat

Dec 20, 2024

HighTower Advisors LLC Acquires New Position in Lantheus Holdings, Inc. (NASDAQ:LNTH) - MarketBeat

Dec 20, 2024

Dec 19, 2024

Lantheus Holdings announces CMO departure, interim leadership in place - Investing.com

Dec 19, 2024

Lantheus Chief Medical Officer Humphrey Departs - MarketWatch

Dec 19, 2024

Lantheus Holdings announces CMO departure, interim leadership in place By Investing.com - Investing.com UK

Dec 19, 2024

Lantheus Announces Departure of Chief Medical Officer - TipRanks

Dec 19, 2024

Lantheus Holdings' SWOT analysis: radiopharmaceutical leader faces market shifts By Investing.com - Investing.com South Africa

Dec 19, 2024

Dec 18, 2024

Lantheus Holdings' SWOT analysis: radiopharmaceutical leader faces market shifts - Investing.com

Dec 18, 2024

Goldman sees upside for lantheus stock, calls Pylarify growth concerns overdone - Investing.com Canada

Dec 18, 2024

P/E Ratio Insights for Lantheus Holdings - Benzinga

Dec 18, 2024

Lantheus (NASDAQ:LNTH) Shares Gap UpHere's Why - MarketBeat

Dec 18, 2024

This Box Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Dec 18, 2024

Lantheus (NASDAQ:LNTH) Earns Buy Rating from Analysts at The Goldman Sachs Group - MarketBeat

Dec 18, 2024

Dec 16, 2024